John A. Auchampach
Department of Pharmacology
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee
Name/email consistency: high
- A Role for the Low-Affinity A2B Adenosine Receptor in Regulating Superoxide Generation by Murine Neutrophils. van der Hoeven, D., Wan, T.C., Gizewski, E.T., Kreckler, L.M., Maas, J.E., Van Orman, J., Ravid, K., Auchampach, J.A. J. Pharmacol. Exp. Ther. (2011)
- Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor. Auchampach, J.A., Gizewski, E.T., Wan, T.C., de Castro, S., Brown, G.G., Jacobson, K.A. Biochem. Pharmacol. (2010)
- Characterization of the A2B adenosine receptor from mouse, rabbit, and dog. Auchampach, J.A., Kreckler, L.M., Wan, T.C., Maas, J.E., van der Hoeven, D., Gizewski, E., Narayanan, J., Maas, G.E. J. Pharmacol. Exp. Ther. (2009)
- Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs. Auchampach, J.A., Jin, X., Moore, J., Wan, T.C., Kreckler, L.M., Ge, Z.D., Narayanan, J., Whalley, E., Kiesman, W., Ticho, B., Smits, G., Gross, G.J. J. Pharmacol. Exp. Ther. (2004)
- A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Auchampach, J.A., Ge, Z.D., Wan, T.C., Moore, J., Gross, G.J. Am. J. Physiol. Heart Circ. Physiol. (2003)
